JP Morgan Healthcare, Day 3: Puma Biotechnology, Natera | Precision Oncology News
Puma Biotechnology falls more than 20%
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Analyst Rating: Will Puma Biotechnology Inc (PBYI) Stock Lead the Market?
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology
Puma Biotechnology, Inc.
Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference | Business Wire
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
PharmaShots - Incisive news in 3 shots on Twitter: "Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer https://t.co/KKTvnp68jJ https://t.co/LR02TGd4oT" / Twitter